Galloflavin mitigates acute kidney injury by suppressing LDHA-dependent macrophage glycolysis
International Immunopharmacology · 2025-03 · 150 · 114265
DOI: 10.1016/j.intimp.2025.114265 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-03. Verfasst von Jie Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei 230601, Anhui, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Macrophages, Isocoumarins, Lactate Dehydrogenase 5. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Postdoctoral Science Foundation, Anhui Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Macrophage-mediated inflammation is closely linked to the pathogenesis of acute kidney injury (AKI) and the shift of macrophages to a pro-inflammatory phenotype being reliant on glycolytic metabolism. Galloflavin, a polyphenol derived from tea, functions as a lactate dehydrogenase A (LDHA) inhibitor, effectively obstructing glycolytic metabolic pathways. However, the specific immunometabolic regulatory functions of galloflavin in macrophages remain unclear. Here, we observed that galloflavin drives alleviation of glycolytic metabolism levels in lipopolysaccharide (LPS)-induced macrophages (RAW264.7 cells and human peripheral blood mononuclear cells-derived macrophages) through downregulation of LDHA expression, thereby inhibiting macrophage conversion to a pro-inflammatory phenotype and reducing the release of inflammatory cytokines. However, the overexpression of LDHA counteracts the effects of galloflavin in macrophages. In addition, in vivo experiments observed a protective effect of galloflavin against cecal ligation and puncture (CLP) and cisplatin-induced renal injury. The ability of galloflavin to inhibit glycolysis in renal macrophages, thereby regulating their phenotypic transition during AKI was further validated through the isolation of renal primary macrophages. This intervention ultimately ameliorated the inflammatory response and decelerated the progression of AKI. Collectively, galloflavin confers protection against AKI by suppressing glycolysis in macrophages through a LDHA-dependent mechanism, thereby positioning it as a potential therapeutic option for AKI in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, the Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei 230601, Anhui, China.
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui…
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
- Department of Nephrology, the Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei 230601, Anhui, China. Electronic address: Wangdeguang@ahmu.edu.cn.
- School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. Electronic address: houchao@ahmu.edu.cn.
Förderung
- China Postdoctoral Science Foundation
- Anhui Provincial Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Wei, J., Chen, X. Y., Wang, Z. J., Li, X. Y., Zhang, M. M., Sun, T., Zhang, X. R., Wang, D. G., Hou, C., & Meng, X. M. (2025). Galloflavin mitigates acute kidney injury by suppressing LDHA-dependent macrophage glycolysis. International Immunopharmacology, 150, 114265. https://doi.org/10.1016/j.intimp.2025.114265
Vancouver
Wei J, Chen XY, Wang ZJ, Li XY, Zhang MM, Sun T, et al. Galloflavin mitigates acute kidney injury by suppressing LDHA-dependent macrophage glycolysis. International Immunopharmacology. 2025;150:114265. doi:10.1016/j.intimp.2025.114265
BibTeX
@article{Wei2025,
author = {Wei, Jie and Chen, Xin-Yu and Wang, Zhi-Juan and Li, Xiang-Yu and Zhang, Meng-Meng and Sun, Tao and Zhang, Xin-Ru and Wang, De-Guang and Hou, Chao and Meng, Xiao-Ming},
title = {Galloflavin mitigates acute kidney injury by suppressing LDHA-dependent macrophage glycolysis},
journal = {International Immunopharmacology},
year = {2025},
volume = {150},
pages = {114265},
doi = {10.1016/j.intimp.2025.114265}
}
EUVIMED